|
Post by orlon on May 10, 2015 14:45:34 GMT -5
But in this case it was no secret. Edstrom had set up a pre-planned sale using rule 10b5-1. The SEC put this rule in place to address the insider trade activity.
|
|
|
Post by orlon on May 10, 2015 11:24:53 GMT -5
There is a certain psychology in the market that investors look at when buying a stock. When the market sees a CEO selling his stock, they think one of several things: He/she is selling for tax purposes, a divorce settlement, or the health of the company is not good. I felt a little uneasy when I saw the new MNKD CEO selling shares on a regular basis, something Al Mann did not do. I don't care if Hakan has ten million shares, he would have demonstrated his confidence in the company even if he bought only 1,000 shares/month instead of selling on a regular basis.
|
|
|
Post by orlon on May 9, 2015 11:48:10 GMT -5
As much as I hate to mention The Street and AF, he did have a point when, during the CC, Hakan mentioned he stopped his insider selling (based on comments from others that it looked bad.) As AF pointed out, if AFREZZA is such a great product, why is the CEO selling stock instead of buying? As CEO, he does not inspire much confidence, especially when you are named CEO and immediately start selling your stock...options or otherwise.
|
|
|
Post by orlon on May 3, 2015 16:39:16 GMT -5
Maybe someone should ask Matt, Hakan or anyone else in management, at what point, prior to becoming a penny stock again, do they start to communicate with the stockholders...you know, the little people, about future plans.
|
|
|
Post by orlon on Apr 23, 2015 20:30:45 GMT -5
I don't dabble in option either but just read the article dated 4/23/15. According to the writer, Ellen Gold, Mannkind is still waiting for approval by FDA. Difficult to trust an article if it is not sufficiently researched.
|
|
|
Post by orlon on Apr 20, 2015 10:51:32 GMT -5
Proxy question number two: Compensation....I voted No! Whatever happened to performance based compensation. This group of management have done absolutely nothing to enhance shareholder value, nor have had a strong enough voice (read balls) to push Sanofi on its AFREZZA launch, never mind the secret plan that some board members speak of, on a product that could be helping millions today. I remember Al Mann dressing down the previous FDA CHIEF on a panel discussion about the time and cost to bring a new drug to market (10 years/1billion dollars) while a whole generation is denied the benefit of a faster approval process. Now that AFREZZA is approved and on the market, little has been done to get the drug/device into the hands of people who could benefit. It's time to shake up the company. No more excuses or BS, no more slow rollout BS...if the product is good, push it, if not pull it. In any event, let's stop pretending the company has no say in how Sanofi markets AFREZZA, it's Mannkind's product. By Jove...I'm beginning to sound like OPC!
|
|
|
Post by orlon on Apr 6, 2015 11:23:21 GMT -5
Visiting family in Boston area during that time. Would like to go but, as with many other quarterly and annual meetings over the past seven years, being dissapointed in the company again is not on the top of my agenda.
|
|
|
Post by orlon on Apr 4, 2015 13:06:00 GMT -5
I'm not sure about the slow rollout but it appears Sanofi is dragging its feet on training their reps and getting the word out about AFREZZA. Most of the rollout appears to me to be Mannkind driven and word of mouth. I'm beginning to question Sanofi's motives behind this partnership.
|
|
|
Post by orlon on Mar 28, 2015 14:37:27 GMT -5
I would be interested to see what motions can pass at the annual meeting since over 86,000,000 shares (35.9%) of the stock is shorted. As Bobw pointed out, those who lent their shares out no longer own the shares, thus do not have voting rights. Those voting rights belong to the 'shorts.'
|
|
|
Post by orlon on Mar 8, 2015 11:45:13 GMT -5
My apologies for being insensitive to your comments regarding your English. My military values are just fine and have not changed over the years. Good luck in your military career and mastering of the English language.
|
|
|
Post by orlon on Mar 7, 2015 13:18:27 GMT -5
TriCare, the military healthcare system for active duty and military retirees, carries AFREZZA with minimum co-pay for 90 day supply. BTW: Most Army medics, at least the ones I have known during my twenty-three military career, had a better grasp of the English language.
|
|
|
Post by orlon on Mar 3, 2015 15:46:50 GMT -5
I feel like I just lost my subscription to the Book of the Month Club!
|
|
|
Post by orlon on Feb 2, 2015 14:39:56 GMT -5
Sorry about the confusion. The co-pay listed prior to 1Feb was $13.00, and yes this is for a 90 day supply, not 90 units. The co-pay after 1 Feb went from $13.00 to $16.00.
|
|
|
Post by orlon on Feb 2, 2015 14:35:01 GMT -5
OOG, The co-pay is $16.00 for a 90 day supply, not 30 days. This is a mail order only from express scripts.
|
|
|
Post by orlon on Feb 2, 2015 13:21:55 GMT -5
Just checked the express scripts site for TriCare cost of AFREZZA...went up $16.00 from $13.00, for a ninety day supply...yes 90 day supply. Now if Sanofi and Mannkind can only do their part in promoting AFREZZA, I can stop taking drugs for depression.
|
|